Josef Leibold
6PUBLICATIONS
67CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 26, 2026
Integrated Chronic In Vivo and In Vitro Screens Uncover NFIL3 as a Driver of T-cell Dysfunction.Nayan Jain, Yuzhe Shi, Celina May
|Jan 06, 2026
CAR-adapted PIK3CD base editing enhances T cell anti-tumor potency.Philip Bucher, Nadine Brückner, Jule Kortendieck
|Jan 04, 2024
Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease.Josef Leibold, Kaloyan M Tsanov, Corina Amor
|Jun 27, 2022
A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma.Phillip M Rappold, Lynda Vuong, Josef Leibold
|Dec 22, 2018
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination.Marcus Ruscetti, Josef Leibold, Matthew J Bott
Pageof 1
Frequent Collaborators
3 joint publications
Judith Feucht
3 joint publications
Scott W Lowe
3 joint publications
Francisco J Sánchez-Rivera
2 joint publications
Celina May
2 joint publications
Michel Sadelain
2 joint publications
Philip Bucher
1 joint publications
Matthew J Bott
1 joint publications
Chi-Chao Chen
1 joint publications
Paul B Romesser
1 joint publications
John T Poirier
